Equities research analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Stock Performance
Shares of CO opened at $1.25 on Monday. The stock has a market cap of $151.94 million, a PE ratio of 1.95 and a beta of 0.16. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The stock has a 50 day simple moving average of $1.38 and a 200-day simple moving average of $1.36.
About Global Cord Blood
Featured Stories
- Five stocks we like better than Global Cord Blood
- Quiet Period Expirations Explained
- Garmin Navigates to New Highs Driven By Wearables Trend
- Stock Dividend Cuts Happen Are You Ready?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Following Congress Stock Trades
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.